Skip to main content
Fig. 3 | BMC Pulmonary Medicine

Fig. 3

From: Clinical significance of cyclin-dependent kinase inhibitor 2C expression in cancers: from small cell lung carcinoma to pan-cancers

Fig. 3

CDKN2C protein levels and the clinical significance of CDKN2C expression in small cell lung carcinoma (SCLC). Panels A–H: The protein levels of CDKN2C in non-SCLC (A, B, E, F) and SCLC (C, D, G, H) tissues under the microscope by in-house tissue microarrays. The left image of each two images is 200x, and the right image is 400x. Panel I: A Kaplan–Meier curve of overall survival between high- and low- CDKN2C expression groups. Panel J: Summary receiver operating characteristic curve for identifying SCLC from the healthy based on CDKN2C expression. Panel K: Summary receiver operating characteristic curve for identifying SCLC from the non-small-cell lung carcinoma based on CDKN2C expression. SENS, sensitivity; SPEC, specificity; AUC, area under the receiver-operating characteristic curve

Back to article page